Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer
ConclusionPPI use was associated with an increased risk of gastric and oesophageal cancer and the risk remained increased over follow-up. These results support our original hypothesis that use of PPIs may be a risk factor for gastric and oesophageal cancer in the general population of maintenance users, independent of underlying indications.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Epidemiology | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Proton Pump Inhibitors PPIs | Study | Sweden Health